Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Irinotecan Following Resection With/Without RFA for Colorectal Cancer Hepatic Metastases
NCT00030563Phase 2Completed
- Sponsor
- University of Washington
- Start
- May 2001
- Primary completion
- Oct 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of irinotecan in colorectal cancer (CRC), sponsored by University of Washington. Started May 2001; status: completed.
02
Drugs
irinotecan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00030563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00030563.